Similarly, Wang and colleagues [13] demonstrated the additive effect of PNPLA3 I148M and TM6SF2 E167K variants on NAFLD in a Chinese cohort. The gene discussed is PNPLA3; the disease is metabolic dysfunction-associated steatotic liver disease.